1) deoxycholic acid
去氧胆酸
1.
The synthesis of cholestane-3,7,24-triol was studied using deoxycholic acid as a starting material.
以去氧胆酸为起始原料,与甲醇反应得到去氧胆酸甲酯,然后在超声波环境下用硼氢化钠-聚乙二醇400-四氢呋喃体系还原得到胆甾-3,7,24-三醇。
2.
By comparing with the molecule weights, retention times and product ion spectra of the standards, the cholic acid, deoxycholic acid and chenodeoxycholic acid were identified in the traditional Chinese compound medicine-"Qingkailing" injection by high performance liquid chromatography/mass spectrometry/mass spectrometry.
采用液相色谱／质谱／质谱法，通过保留时间、分子量和二级质谱的信息对复方“清开灵”注射液中的胆酸、去氧胆酸和鹅去氧腿酸进行了定性；建立了内标法对复方中相对含量较大的胆酸的定量分析方法；结果表明胆酸在８７５ ｎｇ／Ｌ－１４０μｇ／Ｌ范围内线性良好，线性相关系数Ｒ２＝０。
3.
Objective:To develop an HPLC-ELSD method for simultaneous determination of cholic acid,deoxycholic acid and sodium taurocholate in Niudan powder(from Bos Taurus domesticus Gemelin).
目的:建立HPLC-ELSD同时测定动物类药材牛胆粉中胆酸、去氧胆酸和牛黄胆酸钠3种成分含量的方法。
2) chenodeoxycholic acid
鹅去氧胆酸
1.
Design and synthesis of novel molecular clefts based on chenodeoxycholic acid;
新型鹅去氧胆酸分子裂缝的设计合成
2.
Study on the chiral recognition of molecular clefts based on chenodeoxycholic acid;
鹅去氧胆酸分子裂缝对手性分子的识别性能研究
3.
Recognition of neutral molecules by molecular tweezers based on chenodeoxycholic acid;
鹅去氧胆酸分子钳对中性分子的识别性能研究
3) hyodeoxycholic acid
猪去氧胆酸
1.
Determination of chyodeoxycholic acid in Bile Arisaema by HPLC-ELSD;
HPLC测定胆南星中猪去氧胆酸的含量
2.
Determination of hyodeoxycholic acid for Huodan tablets by TLC -scanning;
薄层扫描法测定藿胆片中猪去氧胆酸的含量
3.
Determination of hyodeoxycholic acid in Danhuang tablets by TLC-scanning;
薄层扫描法测定胆黄片中猪去氧胆酸的含量
4) ursodeoxycholic acid
熊去氧胆酸
1.
Determination of ursodeoxycholic acid by pre-column derivation on HPLC;
RP-HPLC柱前衍生化测定熊去氧胆酸的含量
2.
Efficacy and Cost-Effectiveness Analysis of Ursodeoxycholic Acid and Yinchen Compound Injection in Treatment of Biliary Cirrhosis;
熊去氧胆酸联合复方茵陈注射液治疗胆汁性肝硬化的效果及成本分析
3.
Determination of ursodeoxycholic acid in human plasma by liquid chromatography tandem mass spectrometry;
高效液相色谱-串联质谱法测定血浆中熊去氧胆酸的浓度
5) Sodium deoxycholate
去氧胆酸钠
1.
Bacitracin, aprotinin and sodium deoxycholate can in.
在胰岛素口腔喷雾剂中加入酶抑制剂 (杆菌肽、屈来赛多 )和去氧胆酸钠 ,考察了大鼠经口腔喷入胰岛素后的血糖降低情况。
2.
They are Cremophor EL microemulsion by self-emulsifying(PCV-ME6),Cremophor EL microemulsion by homogenizing(PCV-MEho),sodium deoxycholate microemulsion by self-emulsifying(PCV-MEde).
方法考察Cremophor EL自发微乳(PCV-ME6)、Cremophor EL均质微乳(PCV-MEho)和去氧胆酸钠微乳(PCV-MEde)此3种载喷昔洛韦微乳的粒径分布、zeta电位、体外释放及在小鼠体内分布特征。
6) UDCA
熊去氧胆酸
1.
Therapeutic effect of ligustrazine together with heparin sodium and ursodeoxycholic acid (UDCA) on chronic cholestatic hepatitis.;
川芎嗪注射液联合肝素钠与口服熊去氧胆酸治疗慢性淤胆型肝炎疗效观察
2.
Determination of UDCA in plasma and its pharmacokinetics in rabbit;
RP-HPLC法测定兔血浆中熊去氧胆酸的浓度及其药动学研究
3.
The Observation of the Ppatients with Sophora Flavescens Elements and UDCA;
苦参素联合熊去氧胆酸对慢性乙型肝炎GGT的疗效观察
补充资料：去氧胆酸
分子式：C24H40O4
分子量：暂无
CAS号：83-44-3
性质：暂无
制备方法：暂无
用途：利胆药。
分子量：暂无
CAS号：83-44-3
性质：暂无
制备方法：暂无
用途：利胆药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条